Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S.
Lopez J, et al. Among authors: fassier jb.
J Exp Med. 2021 Oct 4;218(10):e20211211. doi: 10.1084/jem.20211211. Epub 2021 Aug 6.
J Exp Med. 2021.
PMID: 34357402
Free PMC article.